Amgen, AstraZeneca announce results from Phase 3 WAYPOINT trial on tezspire | Markets Insider

Amgen (AMGN) and AstraZeneca (AZN) announced full results from the Phase 3, registrational WAYPOINT trial demonstrating that TEZSPIRE significan...

NASDAQ:AMGN NASDAQ:AZN
WS Investor

2025-03-02